After the United Kingdom at the beginning of the week, the United States in turn is preparing to launch a large-scale vaccination campaign. The American Medicines Agency (FDA) has just issued emergency authorization for the vaccine developed by Pfizer and BioNTech laboratories. Across the Channel, many of the first Britons to have received an injection reported the occurrence of mild side effects. Two caregivers, with a history of allergies, also suffered anaphylactic shock. But do we really have to worry about it?
The vaccine data from AstraZeneca and Pfizer / BioNTech were released the same week. For the vaccine developed by the German-American duo, the results appeared in the leading American medical journal The New England Journal of Medicine. An FDA report released Wednesday also sheds light on how the clinical trials went. We learn that more than 80% of people vaccinated, or half of 43,448 volunteers who participated in the study, mentioned pain at the injection site.
Discover the rest of this article for free
Simply enter your email address and set a password
You will receive by e-mail a link allowing you to access this article for free for 48 hours.
If you don’t receive this article within a few minutes, check the junk folder in your email box.
An error has occurred
An error has occurred. Try Again.
Ldiplomacy in all its forms
Lbest of all worlds